New York, January 12, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “South and Central American RNAi Therapeutic Market Weather to 2027 – Impact of COVID-19 and Regional Analysis by Molecule Type , Application, Path of Administration, and End User; and Country “- https://www.reportlinker.com/p06004244/?utm_source=GNW
The closed systems drug transfer device market in South & Central America is largely driven by an increase in chemotherapy uptake and the development of regulatory guidelines regarding dangerous drugs. At least, the lack of regulatory guidelines regarding the safety of health workers in emerging countries is limiting market growth.
In addition, continued technological advances in hazardous drug treatment and an increase in the number of chemotherapeutic drug licenses are expected to drive growth in the South & Central American closed system drug transfer device market during the period. expectation.
Closed system drug transfer devices provide protection against dangerous drugs or valves during drug preparation and administration. These devices include components for filtering hazardous valves.
Closed system drug transfer devices play a major role in protecting health care professionals who are close to antineoplastic drugs and other harmful drugs. Government authorities are emphasizing the implementation of occupational health and safety standards, which, in turn, offer profitable growth opportunities for the South & Central American closed system drug transfer devices market.
Several dangerous drugs, such as monoclonal antibodies, antineoplastics, and antibiotics, are used during patient treatment protocols. Pharmacists, nurses, physicians and other health care workers are at high risk of exposure to dangerous drugs.
Cancer treatment involves the use of antineoplastic drugs that can cause a number of health effects if introduced. The antineoplastic can adversely affect you during pregnancy, and the exposure can lead to chromosomal dysfunction.
Surface contamination of chemotherapy treatment can affect not only health care professionals but also patients and their families. An increasing number of cancer cases are expected to lead to the uptake of chemotherapies.
For example, according to Cancer Atlas, in 2018, approximately 1.3 million new cancer cases and 666,000 cancer deaths were diagnosed in Latin America. The five most common cancers in 2018 were female breast cancer (200,000 new cases, 15% of all cancer cases), prostate cancer (190,000, 14%), colorectal (128,000, 9%), lung (90,000, 7%) and stomach cancer (67,000, 5%). Lung cancer is the leading cause of death (81,000, 12%), followed by colorectal cancer (65,000 10%), prostate (54,000, 8%), female breast (53,000, 8%) and stomach (52,000, 8%) . Thus, the resulting increase in the uptake of chemotherapies would ultimately drive the demand for closed system drug transfer devices in the coming years.
The COVID-19 pandemic has hit the countries of South and Central America causing a major impact on the economy and society. Suddenly, COVID-19 pandemics have disrupted the cancer care spectrum, including delayed diagnosis and treatment and discontinuation of clinical trials.
Along with this, many medical companies have shifted their manufacturing focus from closed-system drug transfer devices to respiratory devices. Such problems tend to adversely affect research and development activity, which would directly hamper the growth of the closed system drug removal devices market in the region.
In 2019, the push-to-turn systems sector accounted for the largest share of the market. The growth of this segment is due to more choice for push-to-turn equipment, as it offers better protection and access to the product including push-to-turn. -to-turn equipment.
In addition, the luer locking systems sector is expected to record the highest CAGR in the closed systems drug removal devices market during the forecast period.
Several key secondary sources cited during the preparation of the South American Central & Middle America closed-loop system drug transfer device market report are Globocan Cancer Statistics 2018, Cancer Atlas group, and Institute Brazilian Cancer National.
Read the full report: https://www.reportlinker.com/p06004244/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest business data so you can get all the market research you need – instantly, in one place.
__________________________
Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001